Singapore, April 8: Engine Biosciences (Engine), a Singapore- and Silicon Valley-based biotechnology company pioneering precision medicine for cancer, announced a new partnership with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and develo
Hyderabad (Telangana) [India], March 18: AI use in medicine to make early diagnosis and predict cancer is new scientific advancement and we are the first India to start about use this technology in collaboration with world famous institutes like MIT, Mayo clinic, The Netherlands and others.
Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being studied as an alternative to chemotherapy and radiotherapy. This is because it directly targets cancer cells, reducing the negative effects associated with more conventi
In a recent study, scientists from The Jackson Laboratory (JAX) and UConn Health not only show how cancer hijacks this tightly regulated splicing and rearranging of RNA but also introduce a potential therapeutic strategy that could slow or even shrink aggressive and hard-to-treat tumors. Thi
In view of the escalating burden of Non-Communicable Diseases (NCDs) in the country, the Ministry of Health & Family Welfare has launched an Intensified Special NCD Screening Campaign today. Running from February 20 to March 31, 2025, this ambitious initiative aims to achieve 100 percen
London [UK]/ Munich [Germany]/ New Delhi [India], February 4: Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimized treatment options for cancer patients who have exhausted the standard options. It integrates a 360° tu
New Delhi [India], January 25: A three-day conference on Peritoneal Surface malignancy was held at Thangam Hospital and Cancer Center, Namakkal. Peritoneal Surface malignancy (PSM) is a super special branch dealing with cancers of peritoeum and which are spread to peritoneum. It is believe
The VMMC and Safdarjung Hospital has successfully performed its first-ever Chimeric Antigen Receptor T-cell (CAR-T) therapy under the leadership of Prof. Sandeep Bansal (Medical Superintendent), a novel treatment for certain types of lymphoma and blood cancers.
London [UK]/ Munich [Germany]/ New Delhi [India], January 22: Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring blood test for solid organ cancers. Target-MRD is a blood test based on tumor-agnostic next-generation s
Chandigarh [India], January 9: RNT Health Insights, a Chandigarh-based health-tech startup specializing in AI-assisted diagnostic solutions for the accurate detection of pathologies during endoscopic procedures, has been granted its second US FDA Breakthrough Device Designation for its Esoph
New Delhi [India], January 8: Thangam Cancer Center, Namakkal, is organizing a three days conference on peritoneal surface malignancies (PSM) on the 10th, 11th and 12th of January 2025. PSM is a super specialized branch dealing with cancers of the peritoneum or which spread to the peritoneum